Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,168.00
(
-0.31%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.64
(
0.84%
)
Bitcoin
71,298.46
(
0.26%
)
News Focus
News Focus

Replies to post #921 on Celsion Corporation (CLSN)

Replies to #921 on Celsion Corporation (CLSN)
icon url

optionking

03/31/12 12:10 PM

#934 RE: biomanbaba #921


Did the management make the decision to extend the trial because they wanted to prove great results with more numbers or were they not getting the desired results with the trial they had conducted as of Nov 11 ?
icon url

optionking

03/31/12 12:11 PM

#935 RE: biomanbaba #921


I assume FDA must have been impressed with PH2 results that they got the orphan status for their drug.